The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

The FDA and EMA's joint guidance was created to ensure the pharmaceutical industry employs best practices when using AI in ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...

A Watertown biotech is suspending drug development and laying off essentially all of its workers in a bid to save cash and ...

FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Teva has penned a second pact with Royalty Pharma, this time securing up to $500 million to support the clinical development ...

The first day of San Francisco’s J.P. Morgan Healthcare Conference, usually punctuated by major announcements of mergers and ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...